{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:05:50Z","timestamp":1787061950456,"version":"build-2736575974"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.thromres.2023.12.014","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T12:12:40Z","timestamp":1704197560000},"page":"75-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Cancer-associated splanchnic vein thrombosis: Clinical implications and management considerations"],"prefix":"10.1016","volume":"234","author":[{"given":"Omri","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia Maria","family":"Caiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarina","family":"Levy-Mendelovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.thromres.2023.12.014_bb0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41572-022-00336-y","article-title":"Cancer-associated venous thromboembolism","volume":"8","author":"Khorana","year":"2022","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"14","key":"10.1016\/j.thromres.2023.12.014_bb0010","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood.2020007338","article-title":"Venous thromboembolism in cancer patients: a population-based cohort study","volume":"137","author":"Mulder","year":"2021","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.thromres.2023.12.014_bb0015","doi-asserted-by":"crossref","first-page":"e566","DOI":"10.1016\/S1470-2045(19)30336-5","article-title":"International Initiative on Thrombosis and Cancer (ITAC) advisory panel. 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer","volume":"20","author":"Farge","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.thromres.2023.12.014_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102190","article-title":"Treatment of venous thromboembolism in cancer patients: the dark side of the moon","volume":"96","author":"Becattini","year":"2021","journal-title":"Cancer Treat. Rev."},{"issue":"6","key":"10.1016\/j.thromres.2023.12.014_bb0025","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.tcm.2022.02.003","article-title":"Unmet clinical needs in the prevention and treatment of cancer-associated venous thromboembolism","volume":"33","author":"Giustozzi","year":"2023","journal-title":"Trends Cardiovasc. Med."},{"issue":"1","key":"10.1016\/j.thromres.2023.12.014_bb0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/ejh.13177","article-title":"Venous thrombosis in unusual sites: a practical review for the hematologist","volume":"102","author":"Shatzel","year":"2019","journal-title":"Eur. J. Haematol."},{"issue":"4","key":"10.1016\/j.thromres.2023.12.014_bb0035","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/jth.15214","article-title":"Clinical history of cancer-associated splanchnic vein thrombosis","volume":"19","author":"Valeriani","year":"2021","journal-title":"J. Thromb. Haemost."},{"issue":"24","key":"10.1016\/j.thromres.2023.12.014_bb0040","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.016600","article-title":"Association of splanchnic vein thrombosis on survival: 15-year institutional experience with 1561 cases","volume":"9","author":"Wells","year":"2020","journal-title":"J. Am. Heart Assoc."},{"issue":"9","key":"10.1016\/j.thromres.2023.12.014_bb0045","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1001\/jamainternmed.2015.3184","article-title":"Long-term clinical outcomes of splanchnic vein thrombosis: results of an international registry","volume":"175","author":"Ageno","year":"2015","journal-title":"JAMA Intern. Med."},{"issue":"4","key":"10.1016\/j.thromres.2023.12.014_bb0050","article-title":"Management of splanchnic vein thrombosis","volume":"5","author":"Elkrief","year":"2023","journal-title":"JHEP Rep."},{"issue":"6","key":"10.1016\/j.thromres.2023.12.014_bb0055","first-page":"713","article-title":"Treatment of portal vein thrombosis: an updated narrative review","volume":"112","author":"Caiano","year":"2021","journal-title":"Minerva Med."},{"issue":"7","key":"10.1016\/j.thromres.2023.12.014_bb0060","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/jth.14836","article-title":"Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC Subcommittee Control of Anticoagulation","volume":"18","author":"Di Nisio","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.thromres.2023.12.014_bb0065","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1055\/s-0040-1722607","article-title":"Cancer-associated splanchnic vein thrombosis","volume":"47","author":"Cohen","year":"2021","journal-title":"Semin. Thromb. Hemost."},{"issue":"1","key":"10.1016\/j.thromres.2023.12.014_bb0070","first-page":"99","article-title":"Antithrombotic treatment of splanchnic vein thrombosis: results of an international registry","volume":"40","author":"Ageno","year":"2014","journal-title":"Semin. Thromb. Hemost."},{"issue":"6","key":"10.1016\/j.thromres.2023.12.014_bb0075","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1016\/S2352-3026(16)30020-5","article-title":"Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: a multicentre, international prospective registry","volume":"3","author":"Riva","year":"2016","journal-title":"Lancet Haematol."},{"issue":"5","key":"10.1016\/j.thromres.2023.12.014_bb0080","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1055\/s-0035-1550429","article-title":"Risk factors, diagnosis, management, and outcome of splanchnic vein thrombosis: a retrospective analysis","volume":"41","author":"Derman","year":"2015","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2023.12.014_bb0085","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.thromres.2019.11.023","article-title":"Splanchnic vein thrombosis predicts worse survival in patients with advanced pancreatic cancer","volume":"185","author":"Afzal","year":"2020","journal-title":"Thromb. Res."},{"issue":"8","key":"10.1016\/j.thromres.2023.12.014_bb0090","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1111\/j.1538-7836.2010.03929.x","article-title":"High rates of symptomatic and incidental thromboembolic events in gastrointestinal cancer patients","volume":"8","author":"Singh","year":"2010","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2023.12.014_bb0095","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1160\/TH16-10-0781","article-title":"Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari Syndrome","volume":"117","author":"Ageno","year":"2017","journal-title":"Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.thromres.2023.12.014_bb0100","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1182\/blood-2015-03-631119","article-title":"Splanchnic venous thrombosis is a marker of cancer and a prognostic factor for cancer survival","volume":"126","author":"S\u00f8gaard","year":"2015","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.thromres.2023.12.014_bb0105","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/ajh.27002","article-title":"Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management","volume":"98","author":"Tefferi","year":"2023","journal-title":"Am. J. Hematol."},{"issue":"5","key":"10.1016\/j.thromres.2023.12.014_bb0110","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ajh.26857","article-title":"Primary myelofibrosis: 2023 update on diagnosis, risk-stratification, and management","volume":"98","author":"Tefferi","year":"2023","journal-title":"Am. J. Hematol."},{"issue":"12","key":"10.1016\/j.thromres.2023.12.014_bb0115","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/ajh.26008","article-title":"Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management","volume":"95","author":"Tefferi","year":"2020","journal-title":"Am. J. Hematol."},{"issue":"6","key":"10.1016\/j.thromres.2023.12.014_bb0120","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1182\/blood-2016-10-695957","article-title":"Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms","volume":"129","author":"Rumi","year":"2017","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.thromres.2023.12.014_bb0125","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1055\/s-0039-1693477","article-title":"Pathogenesis and management of thrombotic disease in myeloproliferative neoplasms","volume":"45","author":"Arachchillage","year":"2019","journal-title":"Semin. Thromb. Hemost."},{"issue":"7","key":"10.1016\/j.thromres.2023.12.014_bb0130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41408-018-0101-8","article-title":"Antithrombotic therapy for venous thromboembolism in myeloproliferative neoplasms","volume":"8","author":"De Stefano","year":"2018","journal-title":"Blood Cancer J."},{"issue":"2","key":"10.1016\/j.thromres.2023.12.014_bb0135","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/ajh.25677","article-title":"Splanchnic vein thromboses associated with myeloproliferative neoplasms: an international, retrospective study on 518 cases","volume":"95","author":"Sant\u2019Antonio","year":"2020","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.thromres.2023.12.014_bb0140","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.blre.2018.06.002","article-title":"Venous thromboembolism incidence in hematologic malignancies","volume":"33","author":"Kekre","year":"2019","journal-title":"Blood Rev."},{"issue":"13","key":"10.1016\/j.thromres.2023.12.014_bb0145","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.3390\/cancers15133477","article-title":"The coagulopathy of acute promyelocytic leukemia: an updated review of pathophysiology, risk stratification, and clinical management","volume":"15","author":"Hermsen","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.thromres.2023.12.014_bb0150","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/jth.14671","article-title":"The prevention and management of asparaginase-related venous thromboembolism in adults: guidance from the SSC on hemostasis and malignancy of the ISTH","volume":"18","author":"Zwicker","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2023.12.014_bb0155","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/ajh.26806","article-title":"Thrombosis in multiple myeloma: risk estimation by induction regimen and association with overall survival","volume":"98","author":"Charalampous","year":"2023","journal-title":"Am. J. Hematol."},{"issue":"10","key":"10.1016\/j.thromres.2023.12.014_bb0160","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3390\/cancers10100380","article-title":"Cancer-associated thrombosis: an overview of mechanisms, risk factors, and treatment","volume":"10","author":"Abdol Razak","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.thromres.2023.12.014_bb0165","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1038\/s41416-022-01968-3","article-title":"Tissue factor in cancer-associated thromboembolism: possible mechanisms and clinical applications","volume":"127","author":"Koizume","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.thromres.2023.12.014_bb0170","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/5584_2016_119","article-title":"Portal vein thrombosis after splenic and pancreatic surgery","volume":"906","author":"Ruiz-Tovar","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2023.12.014_bb0175","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/S0049-3848(16)30092-5","article-title":"Cancer associated thrombosis: risk factors and outcomes","volume":"140","author":"Eichinger","year":"2016","journal-title":"Thromb. Res."},{"issue":"12","key":"10.1016\/j.thromres.2023.12.014_bb0180","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.3748\/wjg.v21.i12.3462","article-title":"Management of hepatocellular carcinoma with portal vein thrombosis","volume":"21","author":"Quirk","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.thromres.2023.12.014_bb0185","first-page":"e207","article-title":"Visceral thromboses in pancreas adenocarcinoma: systematic review","volume":"17","author":"Hicks","year":"2018","journal-title":"Clin. Colorectal Cancer"},{"issue":"23","key":"10.1016\/j.thromres.2023.12.014_bb0190","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1182\/blood-2013-10-531665","article-title":"Causal role for JAK2 V617F in thrombosis","volume":"122","author":"Fleischman","year":"2013","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.thromres.2023.12.014_bb0195","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1182\/blood.2020008109","article-title":"The pathobiology of thrombosis, microvascular disease, and hemorrhage in the myeloproliferative neoplasms","volume":"137","author":"Hasselbalch","year":"2021","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2023.12.014_bb0200","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12657","article-title":"Thrombosis in myeloproliferative neoplasms during cytoreductive and antithrombotic drug treatment","volume":"6","author":"Barbui","year":"2022","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.12.014_bb0205","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.thromres.2022.08.003","article-title":"Splanchnic vein thrombosis associated with myeloproliferative neoplasms","volume":"218","author":"Tremblay","year":"2022","journal-title":"Thromb. Res."},{"issue":"10","key":"10.1016\/j.thromres.2023.12.014_bb0210","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1172\/JCI90312","article-title":"JAK2-V617F promotes venous thrombosis through \u03b21\/\u03b22 integrin activation","volume":"128","author":"Edelmann","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.thromres.2023.12.014_bb0215","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s00277-017-3040-8","article-title":"Thromboses and hemorrhages are common in MPN patients with high JAK2V617F allele burden","volume":"96","author":"Bertozzi","year":"2017","journal-title":"Ann. Hematol."},{"issue":"3","key":"10.1016\/j.thromres.2023.12.014_bb0220","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/2040620716680333","article-title":"Splanchnic vein thrombosis in myeloproliferative neoplasms: pathophysiology and molecular mechanisms of disease","volume":"8","author":"How","year":"2017","journal-title":"Ther. Adv. Hematol."},{"issue":"3","key":"10.1016\/j.thromres.2023.12.014_bb0225","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/leu.2012.290","article-title":"The coagulopathy and thrombotic risk associated with L-asparaginase treatment in adults with acute lymphoblastic leukaemia","volume":"27","author":"Truelove","year":"2013","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.thromres.2023.12.014_bb0230","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/ajh.23158","article-title":"Bleeding and thrombosis in acute promyelocytic leukemia","volume":"87","author":"Choudhry","year":"2012","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.thromres.2023.12.014_bb0235","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.thromres.2017.06.030","article-title":"Clinical manifestations and imaging tools in the diagnosis of splanchnic and cerebral vein thromboses","volume":"163","author":"Riva","year":"2018","journal-title":"Thromb. Res."},{"issue":"6","key":"10.1016\/j.thromres.2023.12.014_bb0240","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.jtha.2023.03.002","article-title":"Clinical course and treatment of incidentally detected splanchnic vein thrombosis: an individual patient data meta-analysis","volume":"21","author":"Candeloro","year":"2023","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2023.12.014_bb0245","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.cgh.2009.09.019","article-title":"Survival and recurrence in patients with splanchnic vein thromboses","volume":"8","author":"Thatipelli","year":"2010","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"18","key":"10.1016\/j.thromres.2023.12.014_bb0250","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1161\/CIRCULATIONAHA.114.012871","article-title":"Mesenteric venous thrombosis","volume":"131","author":"Russell","year":"2015","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.thromres.2023.12.014_bb0255","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/bjs.6319","article-title":"Epidemiology, risk and prognostic factors in mesenteric venous thrombosis","volume":"95","author":"Acosta","year":"2008","journal-title":"Br. J. Surg."},{"issue":"16","key":"10.1016\/j.thromres.2023.12.014_bb0260","doi-asserted-by":"crossref","first-page":"691","DOI":"10.4254\/wjh.v8.i16.691","article-title":"Redefining Budd-Chiari syndrome: a systematic review","volume":"8","author":"Shin","year":"2016","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.thromres.2023.12.014_bb0265","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.thromres.2018.02.143","article-title":"Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis","volume":"164","author":"Tufano","year":"2018","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2023.12.014_bb0270","article-title":"Diagnosis of deep vein thrombosis with D-dimer adjusted to clinical probability: prospective diagnostic management study","volume":"376","author":"Kearon","year":"2022","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.thromres.2023.12.014_bb0275","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3748\/wjg.14.1549","article-title":"High circulating D-dimers are associated with ascites and hepatocellular carcinoma in liver cirrhosis","volume":"14","author":"Spadaro","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.thromres.2023.12.014_bb0280","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.thromres.2021.09.016","article-title":"Diagnostic accuracy of D-dimer in patients at high-risk for splanchnic vein thrombosis: a systematic review and meta-analysis","volume":"207","author":"Riva","year":"2021","journal-title":"Thromb. Res."},{"issue":"29","key":"10.1016\/j.thromres.2023.12.014_bb0285","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000270","article-title":"D-dimer as an early marker of severity in patients with acute superior mesenteric venous thrombosis","volume":"93","author":"Yang","year":"2014","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.thromres.2023.12.014_bb0290","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/liv.14342","article-title":"Congenital antithrombin deficiency in patients with splanchnic vein thrombosis","volume":"40","author":"Baiges","year":"2020","journal-title":"Liver Int."},{"issue":"4","key":"10.1016\/j.thromres.2023.12.014_bb0295","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000496","article-title":"Associations of antiphospholipid antibodies with splanchnic vein thrombosis: a systematic review with meta-analysis","volume":"94","author":"Qi","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.thromres.2023.12.014_bb0300","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2023010177","article-title":"American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing","author":"Middeldorp","year":"2023","journal-title":"Blood Adv."},{"issue":"6","key":"10.1016\/j.thromres.2023.12.014_bb0305","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1016\/j.chest.2021.07.055","article-title":"Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report","volume":"160","author":"Stevens","year":"2021","journal-title":"Chest"},{"issue":"19","key":"10.1016\/j.thromres.2023.12.014_bb0310","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv."},{"issue":"16","key":"10.1016\/j.thromres.2023.12.014_bb0315","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.23.00294","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO guideline update","volume":"41","author":"Key","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.thromres.2023.12.014_bb0320","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","article-title":"American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer","volume":"5","author":"Lyman","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.thromres.2023.12.014_bb0325","doi-asserted-by":"crossref","first-page":"7","DOI":"10.21037\/amj.2018.01.01","article-title":"Approach to thrombophilia testing in patients with splanchnic vein thrombosis","volume":"3","author":"Al-Samkari","year":"2018","journal-title":"AME Med. J."},{"issue":"2","key":"10.1016\/j.thromres.2023.12.014_bb0330","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1160\/th15-04-0326","article-title":"Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment","volume":"115","author":"De Stefano","year":"2016","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2023.12.014_bb0335","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/ajh.26896","article-title":"Myeloproliferative neoplasms and splanchnic vein thrombosis: contemporary diagnostic and therapeutic strategies","volume":"98","author":"Kiladjian","year":"2023","journal-title":"Am. J. Hematol."},{"issue":"6","key":"10.1016\/j.thromres.2023.12.014_bb0340","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00277-023-05217-2","article-title":"Pathological and genomic features of myeloproliferative neoplasms associated with splanchnic vein thrombosis in a single-center cohort","volume":"102","author":"Cattaneo","year":"2023","journal-title":"Ann. Hematol."},{"issue":"1","key":"10.1016\/j.thromres.2023.12.014_bb0345","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jhep.2020.06.045","article-title":"Next-generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis","volume":"74","author":"Magaz","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.thromres.2023.12.014_bb0350","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/101029","article-title":"Imaging diagnosis of splanchnic venous thrombosis","volume":"2015","author":"Rajesh","year":"2015","journal-title":"Gastroenterol. Res. Pract."},{"issue":"3","key":"10.1016\/j.thromres.2023.12.014_bb0355","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/apt.13019","article-title":"Review article: portal vein obstruction--epidemiology, pathogenesis, natural history, prognosis and treatment","volume":"41","author":"Kumar","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.thromres.2023.12.014_bb0360","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/VHRM.S197732","article-title":"Splanchnic vein thrombosis: current perspectives","volume":"15","author":"Valeriani","year":"2019","journal-title":"Vasc. Health Risk Manag."},{"issue":"5","key":"10.1016\/j.thromres.2023.12.014_bb0365","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1200\/JCO.19.01461","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update","volume":"38","author":"Key","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.thromres.2023.12.014_bb0370","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1182\/blood.2020006827","article-title":"Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis","volume":"137","author":"Valeriani","year":"2021","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.thromres.2023.12.014_bb0375","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1055\/s-0040-1722192","article-title":"Anticoagulant treatment for splanchnic vein thrombosis in liver cirrhosis: a systematic review and meta-analysis","volume":"121","author":"Valeriani","year":"2021","journal-title":"Thromb. Haemost."},{"issue":"15","key":"10.1016\/j.thromres.2023.12.014_bb0380","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.1182\/bloodadvances.2022007961","article-title":"Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis","volume":"6","author":"Candeloro","year":"2022","journal-title":"Blood Adv."},{"issue":"2 Suppl","key":"10.1016\/j.thromres.2023.12.014_bb0385","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.thromres.2023.12.014_bb0390","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/rth2.12480","article-title":"Direct oral anticoagulants for unusual-site venous thromboembolism","volume":"5","author":"Riva","year":"2021","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2023.12.014_bb0395","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s10620-015-4012-2","article-title":"Direct oral anticoagulants in cirrhosis patients pose similar risks of bleeding when compared to traditional anticoagulation","volume":"61","author":"Intagliata","year":"2016","journal-title":"Dig. Dis. Sci."},{"issue":"1","key":"10.1016\/j.thromres.2023.12.014_bb0400","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/hepr.12895","article-title":"Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis","volume":"48","author":"Nagaoki","year":"2018","journal-title":"Hepatol. Res."},{"issue":"1","key":"10.1016\/j.thromres.2023.12.014_bb0405","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mayocp.2017.10.007","article-title":"Rivaroxaban and apixaban for initial treatment of acute venous thromboembolism of atypical location","volume":"93","author":"Janczak","year":"2018","journal-title":"Mayo Clin. Proc."},{"issue":"12","key":"10.1016\/j.thromres.2023.12.014_bb0410","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1182\/bloodadvances.2022007397","article-title":"Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study","volume":"6","author":"Ageno","year":"2022","journal-title":"Blood Adv."},{"issue":"Supplement 1","key":"10.1016\/j.thromres.2023.12.014_bb0415","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1182\/blood-2022-168446","article-title":"preliminary result of a pilot study of apixaban in the treatment of splanchnic vein thrombosis","volume":"140","author":"Kim","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2023.12.014_bb0420","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.thromres.2023.06.003","article-title":"Direct oral anticoagulants for the treatment of splanchnic vein thrombosis - a systematic review and meta-analysis","volume":"229","author":"Li","year":"2023","journal-title":"Thromb. Res."},{"issue":"7","key":"10.1016\/j.thromres.2023.12.014_bb0425","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/rth2.12424","article-title":"Anticoagulation in splanchnic and cerebral vein thrombosis: an international vignette-based survey","volume":"4","author":"Riva","year":"2020","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2023.12.014_bb0430","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1002\/hep.27541","article-title":"Use of nontraditional anticoagulants in portal vein thrombosis: a note of caution","volume":"61","author":"Simonetto","year":"2015","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.thromres.2023.12.014_bb0435","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1056\/NEJMoa1711948","article-title":"Edoxaban for the treatment of cancer-associated venous thromboembolism","volume":"378","author":"Raskob","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.thromres.2023.12.014_bb0440","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1200\/JCO.2018.78.8034","article-title":"Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: results of a randomized trial (SELECT-D)","volume":"36","author":"Young","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"17","key":"10.1016\/j.thromres.2023.12.014_bb0445","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJMoa1915103","article-title":"Apixaban for the treatment of venous thromboembolism associated with Cancer","volume":"382","author":"Agnelli","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.thromres.2023.12.014_bb0450","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/jth.14662","article-title":"Apixaban and dalteparin in active malignancy-associated venous thromboembolism: the ADAM VTE trial","volume":"18","author":"McBane","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.thromres.2023.12.014_bb0455","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41408-018-0100-9","article-title":"Splanchnic vein thrombosis in myeloproliferative neoplasms: treatment algorithm 2018","volume":"8","author":"Finazzi","year":"2018","journal-title":"Blood Cancer J."},{"issue":"11","key":"10.1016\/j.thromres.2023.12.014_bb0460","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2016.103","article-title":"Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients","volume":"6","author":"De Stefano","year":"2016","journal-title":"Blood Cancer J."},{"issue":"10","key":"10.1016\/j.thromres.2023.12.014_bb0465","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/leu.2016.85","article-title":"High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists","volume":"30","author":"De Stefano","year":"2016","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.thromres.2023.12.014_bb0470","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1038\/s41375-021-01279-1","article-title":"Direct oral anticoagulants for myeloproliferative neoplasms: results from an international study on 442 patients","volume":"35","author":"Barbui","year":"2021","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.thromres.2023.12.014_bb0475","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/bloodadvances.2020003628","article-title":"A systematic review of antithrombotic treatment of venous thromboembolism in patients with myeloproliferative neoplasms","volume":"5","author":"Hamuly\u00e1k","year":"2021","journal-title":"Blood Adv."},{"issue":"11","key":"10.1016\/j.thromres.2023.12.014_bb0480","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41408-021-00566-5","article-title":"Practice patterns and outcomes of direct oral anticoagulant use in myeloproliferative neoplasm patients","volume":"11","author":"How","year":"2021","journal-title":"Blood Cancer J."},{"issue":"11","key":"10.1016\/j.thromres.2023.12.014_bb0485","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41408-018-0151-y","article-title":"Hydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 cases","volume":"8","author":"De Stefano","year":"2018","journal-title":"Blood Cancer J."},{"issue":"7","key":"10.1016\/j.thromres.2023.12.014_bb0490","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00277-015-2368-1","article-title":"Successful treatment with rivaroxaban of an extended superficial vein thrombosis in a patient with acquired antithrombin deficiency due to Peg-asparaginase treatment","volume":"94","author":"Plander","year":"2015","journal-title":"Ann. Hematol."},{"issue":"4","key":"10.1016\/j.thromres.2023.12.014_bb0495","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00277-017-2930-0","article-title":"Successful treatment with apixaban of sinus venous thrombosis due to pegylated asparaginase in a young adult with T cell acute lymphoblastic leukemia: case report and review of management","volume":"96","author":"Talamo","year":"2017","journal-title":"Ann. Hematol."},{"issue":"2","key":"10.1016\/j.thromres.2023.12.014_bb0500","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00277-014-2198-6","article-title":"Management and outcomes of cancer-associated venous thromboembolism in patients with concomitant thrombocytopenia: a retrospective cohort study","volume":"94","author":"Kopolovic","year":"2015","journal-title":"Ann. Hematol."},{"issue":"11","key":"10.1016\/j.thromres.2023.12.014_bb0505","doi-asserted-by":"crossref","first-page":"E468","DOI":"10.1002\/ajh.24526","article-title":"Venous thromboembolism in patients with hematologic malignancy and thrombocytopenia","volume":"91","author":"Khanal","year":"2016","journal-title":"Am. J. Hematol."},{"issue":"24","key":"10.1016\/j.thromres.2023.12.014_bb0510","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1182\/bloodadvances.2021005966","article-title":"Anticoagulation in cancer-associated thromboembolism with thrombocytopenia: a prospective, multicenter cohort study","volume":"5","author":"Carney","year":"2021","journal-title":"Blood Adv."},{"issue":"6","key":"10.1016\/j.thromres.2023.12.014_bb0515","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/jth.14015","article-title":"Management of cancer-associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH","volume":"16","author":"Samuelson Bannow","year":"2018","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2023.12.014_bb0520","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1160\/TH08-01-0015","article-title":"Risks and benefits of transcatheter thrombolytic therapy in patients with splanchnic venous thrombosis","volume":"100","author":"Smalberg","year":"2008","journal-title":"Thromb. Haemost."},{"issue":"18","key":"10.1016\/j.thromres.2023.12.014_bb0525","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.3748\/wjg.v20.i18.5483","article-title":"Initial transcatheter thrombolysis for acute superior mesenteric venous thrombosis","volume":"20","author":"Yang","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.thromres.2023.12.014_bb0530","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.avsg.2016.02.019","article-title":"Postoperative catheter-directed thrombolysis versus systemic anticoagulation for acute superior mesenteric venous thrombosis","volume":"35","author":"Yang","year":"2016","journal-title":"Ann. Vasc. Surg."},{"issue":"34","key":"10.1016\/j.thromres.2023.12.014_bb0535","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.3748\/wjg.v26.i34.5060","article-title":"Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: a comprehensive review","volume":"26","author":"Inchingolo","year":"2020","journal-title":"World J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.thromres.2023.12.014_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2021.07.018","article-title":"North American practice-based recommendations for transjugular intrahepatic portosystemic shunts in portal hypertension","volume":"20","author":"Boike","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.thromres.2023.12.014_bb0545","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/hep.26306","article-title":"Good long-term outcome of Budd-Chiari syndrome with a step-wise management","volume":"57","author":"Seijo","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.thromres.2023.12.014_bb0550","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jvir.2020.08.035","article-title":"Long-term outcomes of endovascular interventions in more than 500 patients with Budd-Chiari syndrome","volume":"32","author":"Hemachandran","year":"2021","journal-title":"J. Vasc. Interv. Radiol."},{"issue":"1","key":"10.1016\/j.thromres.2023.12.014_bb0555","doi-asserted-by":"crossref","first-page":"16166","DOI":"10.1038\/s41598-022-20399-x","article-title":"Evaluation of outcome from endovascular therapy for Budd-Chiari syndrome: a systematic review and meta-analysis","volume":"12","author":"Mukhiya","year":"2022","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.thromres.2023.12.014_bb0560","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000513368","article-title":"Trends and in-hospital outcomes of splanchnic vein thrombosis associated with gastrointestinal malignancies: a nationwide analysis","volume":"8","author":"Handa","year":"2021","journal-title":"Gastrointest. Tumors"},{"issue":"12","key":"10.1016\/j.thromres.2023.12.014_bb0565","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1002\/ajh.25270","article-title":"Myeloproliferative neoplasms in the young: Mayo Clinic experience with 361 patients age 40 years or younger","volume":"93","author":"Szuber","year":"2018","journal-title":"Am. J. Hematol."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823003584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823003584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:52:17Z","timestamp":1758736337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384823003584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":113,"alternative-id":["S0049384823003584"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2023.12.014","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer-associated splanchnic vein thrombosis: Clinical implications and management considerations","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2023.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}